These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 9496252)

  • 1. Control of matrix metalloproteinase activity in cancer.
    Jones JL; Walker RA
    J Pathol; 1997 Dec; 183(4):377-9. PubMed ID: 9496252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease.
    Ries C; Petrides PE
    Biol Chem Hoppe Seyler; 1995 Jun; 376(6):345-55. PubMed ID: 7576228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour invasion and matrix metalloproteinases.
    Polette M; Nawrocki-Raby B; Gilles C; Clavel C; Birembaut P
    Crit Rev Oncol Hematol; 2004 Mar; 49(3):179-86. PubMed ID: 15036258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
    Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
    J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current data on metalloproteinases, obligatory partners of tumor progression].
    Rémy L
    Pathol Biol (Paris); 1997 Nov; 45(9):759-65. PubMed ID: 9538475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases and their inhibitors.
    Kugler A
    Anticancer Res; 1999; 19(2C):1589-92. PubMed ID: 10365151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular matrix remodelling: the role of matrix metalloproteinases.
    Stamenkovic I
    J Pathol; 2003 Jul; 200(4):448-64. PubMed ID: 12845612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex roles of tissue inhibitors of metalloproteinases in cancer.
    Jiang Y; Goldberg ID; Shi YE
    Oncogene; 2002 Mar; 21(14):2245-52. PubMed ID: 11948407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor cell-matrix interaction: pericellular matrix degradation and metastasis.
    Okada Y
    Verh Dtsch Ges Pathol; 2000; 84():33-42. PubMed ID: 11217446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and cancer.
    Cox G; O'Byrne KJ
    Anticancer Res; 2001; 21(6B):4207-19. PubMed ID: 11908674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Matrix metalloproteinases and colorectal cancer].
    Roeb E; Matern S
    Med Klin (Munich); 2003 Dec; 98(12):763-70. PubMed ID: 14685678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of matrix metalloproteinases in melanoma cell invasion.
    Hofmann UB; Houben R; Bröcker EB; Becker JC
    Biochimie; 2005; 87(3-4):307-14. PubMed ID: 15781317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia.
    Poincloux R; Lizárraga F; Chavrier P
    J Cell Sci; 2009 Sep; 122(Pt 17):3015-24. PubMed ID: 19692588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].
    Hamacher S; Matern S; Roeb E
    Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial collagenases as markers of tumor progression.
    Brinckerhoff CE; Rutter JL; Benbow U
    Clin Cancer Res; 2000 Dec; 6(12):4823-30. PubMed ID: 11156241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases in neoplasm-induced extracellular matrix remodeling in breast carcinomas.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 2001; 21(3B):2021-8. PubMed ID: 11497292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes.
    Parmo-Cabañas M; Molina-Ortiz I; Matías-Román S; García-Bernal D; Carvajal-Vergara X; Valle I; Pandiella A; Arroyo AG; Teixidó J
    J Pathol; 2006 Jan; 208(1):108-18. PubMed ID: 16278822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.
    Collins HM; Morris TM; Watson SA
    Br J Cancer; 2001 Jun; 84(12):1664-70. PubMed ID: 11401321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression.
    Crawford HC; Matrisian LM
    Invasion Metastasis; 1994-1995; 14(1-6):234-45. PubMed ID: 7657516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.